SEC Form 4 · accession 0001179110-15-010118
MOMENTA PHARMACEUTICALS INC · MNTA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Bruce Leicher
Officer — SVP & General Counsel
Period of report
Jun 18, 2015
Accepted (ET)
Jun 22, 2015 · 2:19 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001235010
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 18, 2015 | M | 13,548 | $15.12 | A | 131,365 | D | |
| Common Stock | Jun 18, 2015 | S | 13,548 | $23.00 | D | 117,817 | D | |
| Common Stock | Jun 18, 2015 | M | 6,452 | $15.12 | A | 124,269 | D | |
| Common Stock | Jun 18, 2015 | S | 6,452 | $23.00 | D | 117,817 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $15.12 | Jun 18, 2015 | M | 13,548 | D | Aug 19, 2012 | Aug 19, 2018 | Common Stock | 13,548 | 6,452 | D |
| Stock Option (Right to Buy) | $15.12 | Jun 18, 2015 | M | 6,452 | D | Aug 19, 2012 | Aug 19, 2018 | Common Stock | 6,452 | 0 | D |
Explanation of responses
- F1This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 5, 2013.